Skip to main content

Table 4 The risk factors for early NAI administration by the clinicians

From: The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Variable

p-value

OR (95% CI)

Positive for RIDTs

< 0.001

3.586 (1.259–10.219)

  1. RIDTs Rapid influenza diagnostic tests
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us